VirtualScopics — Q2 2015 Earnings Presentation
8 slides from VirtualScopics's earnings presentation, Aug 11, 2015
Slide 1: Second Quarter 2015 Performance Review
Second Quarter 2015 Performance Review August 11, 2015
Slide 2: Forward-looking Statements
Forward - looking Statements The statements contained in this press release that are not purely historical are forward - looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are intende
Slide 3: Second Quarter 2015 Financial Review
Second Quarter 2015 Financial Review 3
Slide 4: June 30, 2015 Balance Sheet
June 30, 2015 Balance Sheet June 30 December 31, 2015 2014 (Unaudited) Assets Current assets Cash $ 1,651,791 $ 4,046,599 Accounts receivable, net 21590,123 qis14.143, Prepaid expenses and other current assets 3801231 410.188 ‘Total current assets 4,622,145 6,270,930 Patents, net 1,115,889 4,211,770
Slide 5: Double Digit Revenue Growth Continues
CEO Comments • Double Digit Revenue Growth Continues − Cash burn reduced • $2 Million Line of Credit With Silicon Valley Bank • Trial Tracker Software Ahead of Plans • More Market Awareness − Interviews − Published articles 5
Slide 6: Targeting BioTechs
CEO Comments • Targeting BioTechs • Success of Live Seminars − New Hope − Boston • IXICO Alliance − Next live seminar with IXICO in New Hope • Pricing Discussions with Customers − Early phase reputation is strong 6
Slide 7: Still Targeting Phase Growth
CEO Comments • Still Targeting Phase 3 Growth − Expanded reader – radiologist resources − Core radiologist group still extremely valuable • Flexibility Keeps Us Strong − Various trial size − No one size fits all • Critical Mass A Growing Focus 7
Slide 8: Thank You Questions and Answers
Thank You Questions and Answers